Urgent.News

What's breaking now, across thousands of outlets.

Business

Flop of new medication costs Novartis dearly

The pharmaceutical company has to write off almost two billion dollars because a potential new drug did not show the desired effect. The company's CEO is downplaying the failure. However, many market observers are skeptical.

Translated from German Read in German

Flop of new medication costs Novartis dearly

We haven't written up this one. NZZ Wirtschaft has the full story — the link below goes straight to it.

Read the original at nzz.ch →

More in Business

2027 Tax Foundation Europe Conference

Join us for Tax Foundation Europe’s 2027 Conference, where we will bring together leaders from the international tax community to discuss major tax topics, hear from top academics on new research, and…

More from Tuesday 27 October →